NASDAQ
0.83USD
-0.10 (-10.38%)
We have scored 4 news catalysts on BioCardia, Inc. (BCDA) over the past 12 months. The biggest single-day move next to one of them came Mar 24, 2026, when BCDA closed +0.8%: “BioCardia Reports 2025 Business Highlights and Financial Results”. Coverage across the window leans positive (average ticker sentiment +0.15). Most of the impact sits in short squeeze potential and sector healthcare.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
12.5M
P/E
—
EPS
—
Beta
0.49
52W range
0.661-1.8
Day range
0.66–0.95
Open
0.95
Prev close
0.92
Volume
287.9K
Avg volume
249.5K
Dividend
0.00
IPO
1996-11-13
BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respiratory ailments. Central to its pipeline is the CardiAMP Cell Therapy System, designed to address heart failure and chronic myocardial ischemia. Additionally, BioCardia is advancing an allogeneic cell therapy program, also targeting cardiac and pulmonary conditions. The company is further exploring a specific allogeneic cell therapeutic platform. This investigational treatment, derived from culture-expanded mesenchymal cells sourced from bone marrow, is currently undergoing Phase I/II trials for patients suffering from ischemic systolic heart failure. Beyond its therapeutic candidates, BioCardia also provides innovative delivery solutions. These include the Helix biotherapeutic delivery system, engineered to precisely administer treatments directly into the heart muscle via an internal penetrating helical needle, and a line of Morph deflectable guides and sheaths. BioCardia maintains its headquarters in Sunnyvale, California.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about BioCardia, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for BCDA: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
